NASDAQ: GILD · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Gilead Sciences Inc.

How Gilead Sciences Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$205.3B

Price

$165.61

P/E

-53.2

EPS (TTM)

$-3.11

1-year return

39.8%

Dividend yield

2.0%

52-week range

$118.15–$165.61

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector
• S&P 500
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources